Document Detail


Detecting, predicting and modifying cardiovascular risk: new and developing strategies.
MedLine Citation:
PMID:  21090925     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Cardiovascular disease is a leading cause of mortality across Europe and the USA. Epidemiological studies and randomized clinical trials provide strong evidence that coronary disease is largely preventable and can be attributed principally to nine modifiable risk factors. However, a large proportion of coronary events occur in individuals who have intermediate levels of these risk factors, motivating the search for novel markers to improve screening and risk stratification. Work presented at the 78th European Atherosclerosis Society Congress outlined challenges faced in primary prevention as well as novel findings for risk factors. This article focuses on some of these factors, as well as risk prediction and detection, and concludes with the current state of antiatherogenic treatment strategies.
Authors:
Tina Shah; Daniel Swerdlow
Related Documents :
22759975 - Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on hodg...
20649935 - Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome.
4020335 - An assessment of the practice of preventive cardiology in an academic health center.
18483765 - Different distribution of cardiovascular risk factors according to ethnicity: a study i...
22705435 - Lack of folate improvement in high risk indigenous australian adults over an average of...
11854335 - Is the link between alcohol and cardiovascular death among young russian men attributab...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  8     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1519-21     Citation Subset:  IM    
Affiliation:
Centre for Clinical Pharmacology, British Heart Foundation Laboratories at UCL, Rayne Building, 5 University Street, London, WC1E 6JJ, UK. t.shah@ucl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results.
Next Document:  Choosing an antihypertensive combination with a more efficient central blood pressure reduction.